Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-07 Option Award |
2025-03-11 4:14 pm |
N/A 2035-03-06 |
Senti Biosciences Inc. | SNTI | Cross John Harry III Chief Financial Officer |
174,200 | $0 | 174,200 (Direct) |
View |
2023-12-11 Option Award |
2024-12-05 9:55 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Cross John Harry III Chief Financial Officer |
1,452 | $0 | 1,588 (Direct) |
View |
2023-02-06 Tax Withholding |
2023-02-17 4:45 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Cross John Harry III Chief Financial Officer |
1,960 | $1.06 | 23,927 (Direct) |
View |
2022-12-14 Option Award |
2022-12-22 4:31 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Cross John Harry III Chief Financial Officer |
15,519 | $0 | 160,684 (Direct) |
View |
2021-12-15 Option Award |
2022-04-08 4:30 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Cross John Harry III Chief Financial Officer |
66,951 | $0 | 145,165 (Direct) |
View |
2020-07-02 Option Award |
2020-07-02 6:17 pm |
N/A N/A |
Sonnet BioTherapeutics Holdings Inc. | SONN | Cross John Harry III Chief Financial Officer |
78,214 | $0 | 78,214 (Direct) |
View |